Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 7, Issue 10 (2018)

Effectiveness of migraine prophylaxis on psychiatric changes and quality of sleep

Author(s):
Tarunika Reddy P, Sri Lalitha YNS, Sreekanth Vemula, Narender Boggula and Vasudha Bakshi
Abstract:
Background: Migraine is a 6th leading causes of disability worldwide. It is classified into two major types, migraine with aura and migraine without aura. Migraine is often associated with comorbid Psychiatric changes and poor quality of sleep. Migraine prophylactic therapy is used to reduce the frequency, severity and disability of migraine attacks. Along with headache, an appropriate prophylactic drug can show effect in treating comorbid conditions associated with migraine and improve sleep.
Objectives: The aim of the study is to show the effect of migraine prophylaxis on Psychiatric changes and Quality of sleep. Besides, the objective of our study is to determine frequency, severity and duration of migraine, severity of depression and anxiety and their minimization.
Methods: About 150 patients above 10 years where included in the study. The required data was collected from the patients through direct interview using standard questionnaires. The acquired data was evaluated based on the standard questionnaire scales i.e. Migraine Disability Assessment Scale, Zung Self Rating Depression scale, Zung Self-Rating Anxiety scale and Pittsburgh Sleep Quality Index were used to diagnose the severity of migraine, anxiety and depression along with impaired quality of sleep in migraine patients.
Results: We found a higher significant prevalence and risk of incident migraine is in females than in males. Age groups of 25-45 years are at a higher risk of migraine incidence. Prevalence of mild to severe depression (according to Zung Self-Rating Depression Scale) 29.3% and moderate to severe anxiety (according to Zung Self-Rating Anxiety Scale) is 27.3%. The study shows prevalence of migraine without aura (83%) is higher than migraine with aura (6%). In our study Propranolol (46.67%), Topiramate (39%), Amitriptyline (32%) were the most prescribed drugs. All the three drugs has shown an effect on frequency, severity, duration of headache with the significance of P<0.01 similarly these drugs has shown a significant difference in scores of migraine disability assessment index, Zung self rating depression scale, Zung self-rating anxiety scale and Pittsburgh sleep quality index (P<0.01).
Conclusion: Propranolol was the most prescribed drug among all the prophylactic drugs prescribed. Out of all the prophylactic drugs propranolol, amitriptyline, topiramate when used individually or in combination form it was observed that there is decrease in factors such as migraine frequency, severity, duration, MIDAS scores, depression and anxiety, whereas quality of sleep improved. In our study we also observed that not only amitriptyline (anti-depressant) but also propranolol and topiramate showed effect on Psychiatric symptoms and quality of sleep.
Pages: 212-224  |  702 Views  58 Downloads


The Pharma Innovation Journal
How to cite this article:
Tarunika Reddy P, Sri Lalitha YNS, Sreekanth Vemula, Narender Boggula, Vasudha Bakshi. Effectiveness of migraine prophylaxis on psychiatric changes and quality of sleep. Pharma Innovation 2018;7(10):212-224.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter